InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Fmr Llc, a TenPercentOwnerOther, is a corporate insider tracked by InsiderTape across 5 companies. The public record shows 22 open-market SEC Form 4 transactions: 1 purchase worth $8.7M and 21 sales worth $47.9M, reported from Jan 26, 22 to Jun 26, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 26 | BEAMBeam Therapeutics Inc. | SELL | 251.5K | $35.26 | $8.9M |
| Jun 25, 26 | BEAMBeam Therapeutics Inc. | SELL | 33.4K | $35.12 | $1.2M |
| Nov 3, 25 | MTSRMetsera, Inc. | SELL | 193 | $61.23 | $12K |
| Oct 27, 25 | BEAMBeam Therapeutics Inc. | SELL | 459 | $26.68 | $12K |
| Sep 2, 25 | MTSRMetsera, Inc. | SELL | 268 | $36.00 | $10K |
| Jul 30, 25 | BEAMBeam Therapeutics Inc. | SELL | 48.4K | $20.50 | $992K |
| Jan 8, 25 | SANASana Biotechnology, Inc. | SELL | 164.9K | $7.26 | $1.1M |
| Feb 14, 24 | BEAMBeam Therapeutics Inc. | SELL | 854.3K | $31.34 | $26.1M |
| Feb 13, 24 | BEAMBeam Therapeutics Inc. | SELL | 1.2K | $30.93 | $36K |
| Jun 27, 23 | NONEFidelity Private Credit Fund | BUY | 346.7K | $25.23 | $8.7M |
| Sep 6, 22 | BEAMBeam Therapeutics Inc. | SELL | 551 | $54.25 | $30K |
| Aug 5, 22 | BEAMBeam Therapeutics Inc. | SELL | 20.2K | $61.00 | $1.2M |
| Jul 12, 22 | VERVVerve Therapeutics, Inc. | SELL | 100.0K | $22.04 | $2.0M |
| Jul 1, 22 | VERVVerve Therapeutics, Inc. | SELL | 38.8K | $15.66 | $607K |
| Jun 30, 22 | VERVVerve Therapeutics, Inc. | SELL | 18.8K | $15.21 | $286K |
| Jun 29, 22 | VERVVerve Therapeutics, Inc. | SELL | 30.4K | $15.60 | $474K |
| Apr 13, 22 | BEAMBeam Therapeutics Inc. | SELL | 8.8K | $50.80 | $440K |
| Mar 9, 22 | VERVVerve Therapeutics, Inc. | SELL | 4.0K | $29.01 | $115K |
| Feb 9, 22 | VERVVerve Therapeutics, Inc. | SELL | 13.2K | $29.46 | $389K |
| Feb 1, 22 | VERVVerve Therapeutics, Inc. | SELL | 35.6K | $29.04 | $1.0M |
| Jan 27, 22 | VERVVerve Therapeutics, Inc. | SELL | 8.7K | $30.02 | $256K |
| Jan 26, 22 | VERVVerve Therapeutics, Inc. | SELL | 89.0K | $31.96 | $2.8M |